Table of Contents
- Introduction
- From Toxins To Genomics: The Expanding Scope Of Environmental Health
- Wastewater Epidemiology: The New Frontier In Public Health
- Antimicrobial Resistance: A Silent Global Emergency
- Unearthing New Microbial Frontiers
- Sequencing The UAE’s Ecological Soul: The GHAF Project
- A Lab Built From Imagination, Grit, and Serendipity.
- Designing The Future Of Environmental Health
Introduction
Four years ago, a barren plot of land in Abu Dhabi held no clues to the global scientific powerhouse it would soon become. With a bold vision to explore the non-clinical drivers of health and a deliberate mandate to operate at the intersection of public health, environmental science and advanced technology, M42 launched its Environmental Sciences (EVS) division. EVS is a first-of-its-kind department focused on environmental drivers of health, with a bold vision, expert talent and state-of-the-art technology. It collaborated with the Abu Dhabi Quality and Conformity Council (ADQCC). Together, they built not just a laboratory, but a paradigm shift: one that sees the environment not as background noise, but a rich data layer that can be used to safeguard public health.
The result is RASID: a cutting-edge laboratory and scientific institution. It’s now recognized by leading global academic centers, including Imperial College London and the University of Cambridge. It stands as a living model of integrated science, policy and innovation. Its very existence is proof of what’s possible when ambition meets execution.
“We built something extraordinary, from the ground up,” says Dr. Wael Elamin, Medical Director of Environmental Sciences (EVS) at M42. “In just 18 months, we launched one of the world’s largest and most advanced mass spectrometry labs.”
From Toxins to Genomics: the Expanding Scope of Environmental Health
M42’s EVS division explores the often-invisible factors that shape population health, from airborne toxins and antimicrobial resistance to biosurveillance, food systems and marine ecosystems.
At its core is a data-drive. An AI-enhanced approach helps transform complex environmental signals into actionable insights. Through advanced lab design, regulatory-grade testing, genomic surveillance, and scientific publishing, EVS is not just reacting to environmental risks, it is anticipating them.
“Many talk about intent. We focus on execution,” says Dr. Elamin. “To date, we have published over 40 tier-one scientific papers and presented at global forums including environmental agencies.”
Wastewater Epidemiology: the New Frontier in Public Health
Wastewater surveillance is fast becoming an essential global tool for monitoring public health threats. EVS is at the vanguard of this shift.
Wastewater analysis was originally used to track pathogens transmitted via the fecal-oral route. It is now a cost-effective, population-wide diagnostic tool. Capable of detecting infectious diseases early and tracking viral mutations, it is also guiding real-time interventions.
“We are building what I believe will become the global reference point for wastewater-based epidemiology,” Dr. Elamin notes. “We’re not just studying it, we’re shaping the science itself.”
During the COVID-19 pandemic, wastewater-based epidemiology proved indispensable. It played a central role in gauging community infection trends, tracking viral mutations, and pinpointing emerging hotspots – all without the need for widespread individual testing. Now, EVS is using the same infrastructure to monitor a broader array of threats.
Antimicrobial Resistance: a Silent Global Emergency
Among EVS’s most urgent priorities is antimicrobial resistance (AMR) – one of the world’s most pressing public health concerns, responsible for an estimated 1.27 million deaths in 2019, and a contributing factor in nearly 5 million more .
“What makes our wastewater approach unique is its ability to see what clinical sampling often misses,” says Dr. Elamin. “We track pathogens that persist in harsh conditions – resistant not just to antibiotics, but to heat, disinfectants, and chemicals. These insights reveal how resistance traits emerge, evolve and spread.”
As the team observes AMR, they are helping chart a course to counteract it, with implications for drug development, infection control, and global health policy.
Unearthing New Microbial Frontiers
AMR surveillance is only part of the picture. EVS scientists are also identifying novel microbes, sequencing resistance genes, and cataloging pathogens with pharmaceutical relevance. Their work includes:
- Full whole-genome sequencing of Candida auris from environmental samples and the early identification of a new clade – a first-of-its-kind achievement
- A surveillance or respiratory syncytial virus (RSV), rhinoviruses, human metapneumovirus, and other respiratory pathogens
“No one knows C. auris’s natural habitat. With fewer than 250 complete genomes of C. auris globally, our contributions are both unique and urgent.”
Sequencing the UAE’s Ecological Soul: the GHAF Project
Beyond infectious threats, EVS is pioneering work with environmental DNA (eDNA) through projects like GHAF, in collaboration with the Environmental Agency of Abu Dhabi and Bayanat (now Space42).
This effort complemented the first full genome sequence of the Ghaf tree (Prosopis cineraria), originally completed by UAE University and published in 2022. EVS’ contribution applied long-read whole genome sequencing to build on that foundation. But the implications go further. EVS is mapping gene expression, protein pathways and the microbial and fungal communities that coexist with desert plants.
This work could fuel bioprospecting for new compounds in agriculture, medicine and biotech. It echoes the kinds of discoveries that won the 2021 Nobel Prize in Chemistry.
A Lab Built from Imagination, Grit, and Serendipity.
Looking back, Dr. Elamin sees more than just infrastructure and assays. He sees a story of audacity.
“During the COVID-19 pandemic, my colleague Greg and I were both at personal inflection points. Together, we imagined a lab like no other. We designed our own robots. We validated our own assays. We didn’t just propose ideas, we proved them.”
Designing the Future of Environmental Health
From ancient Mesopotamian sewage systems to today’s AI-powered biosurveillance, the arc of civilization is traced through how we manage waste, water and the invisible microbial worlds around us.
For M42’s EVS team, the work underway is only the beginning. What started on an empty plot of land now influences global science, public health preparedness and the very future of environmental medicine.
“This is the spirit of scientific adventure: the joy of asking impossible questions and designing the future with your own hands.”
By accessing, listening to or reading Beyond Bounds content, you acknowledge and agree that the views expressed by guests and contributors are their own and do not necessarily reflect the views of M42.
All content is provided for general informational purposes only and is not intended as, and should not be relied upon as, medical advice, diagnosis or treatment. Always consult a suitably qualified healthcare professional regarding any medical condition or healthcare decision. Accessing Beyond Bounds content does not create a doctor–patient, clinical, advisory or other professional relationship.
References or links to third-party content, products, services or resources are provided for informational purposes only and do not constitute or imply endorsement by M42. To the fullest extent permitted by applicable law, M42 accepts no liability for any loss, damage or other consequence arising from, or in connection with, access to or reliance upon content in Beyond Bounds.
This disclaimer shall be governed by and construed in accordance with the laws of the United Arab Emirates as applicable in the Emirate of Abu Dhabi. Any dispute arising out of or in connection with this disclaimer shall be subject to the exclusive jurisdiction of the courts of the Emirate of Abu Dhabi.